OraSure Technologies (OSUR) Competitors $3.28 -0.06 (-1.65%) As of 02:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OSUR vs. CERS, UTMD, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. OraSure Technologies vs. Its Competitors Cerus Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk. Do insiders & institutionals hold more shares of OSUR or CERS? 93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 3.9% of OraSure Technologies shares are owned by insiders. Comparatively, 5.6% of Cerus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to OSUR or CERS? In the previous week, OraSure Technologies and OraSure Technologies both had 5 articles in the media. Cerus' average media sentiment score of 1.00 beat OraSure Technologies' score of 0.43 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Cerus 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, OSUR or CERS? OraSure Technologies has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Do analysts recommend OSUR or CERS? OraSure Technologies presently has a consensus target price of $3.00, suggesting a potential downside of 8.68%. Cerus has a consensus target price of $3.50, suggesting a potential upside of 164.15%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is OSUR or CERS more profitable? Cerus has a net margin of -9.81% compared to OraSure Technologies' net margin of -36.84%. OraSure Technologies' return on equity of -10.81% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies-36.84% -10.81% -9.44% Cerus -9.81%-33.77%-9.32% Which has better valuation & earnings, OSUR or CERS? OraSure Technologies has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$185.83M1.29-$19.50M-$0.67-4.90Cerus$180.27M1.41-$20.92M-$0.10-13.25 SummaryCerus beats OraSure Technologies on 10 of the 15 factors compared between the two stocks. Get OraSure Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSUR vs. The Competition Export to ExcelMetricOraSure TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$240.27M$10.56B$5.75B$9.84BDividend YieldN/A1.86%3.95%4.02%P/E Ratio-4.9021.7430.7626.60Price / Sales1.2931.35459.33120.41Price / Cash89.6424.9437.7659.36Price / Book0.633.5110.036.70Net Income-$19.50M$210.11M$3.27B$265.68M7 Day Performance14.86%5.50%3.36%3.42%1 Month Performance-1.94%12.26%4.58%1.09%1 Year Performance-24.48%-5.75%44.38%23.94% OraSure Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSUROraSure Technologies2.2748 of 5 stars$3.29-1.6%$3.00-8.7%-23.7%$240.27M$185.83M-4.90840CERSCerus2.9402 of 5 stars$1.28+1.2%$3.50+173.4%-43.5%$242.50M$180.27M-12.80290UTMDUtah Medical Products2.7745 of 5 stars$60.34-1.0%N/A-10.1%$195.37M$40.90M16.13180News CoverageANIKAnika Therapeutics4.3621 of 5 stars$9.13-5.4%$18.00+97.2%-63.3%$139.13M$119.91M-2.20300WSTWest Pharmaceutical Services4.7252 of 5 stars$246.98-0.4%$320.71+29.9%-18.7%$17.82B$2.89B36.9710,600Positive NewsCOOCooper Companies4.0958 of 5 stars$73.48-2.3%$96.73+31.6%-21.5%$15.04B$3.90B35.6716,000Trending NewsEarnings ReportAnalyst ForecastGap DownALGNAlign Technology4.9465 of 5 stars$144.96-3.1%$215.00+48.3%-39.9%$10.84B$4.00B24.4520,945MMSIMerit Medical Systems4.4786 of 5 stars$88.16-1.4%$107.00+21.4%-3.2%$5.30B$1.36B44.757,400News CoveragePositive NewsInsider TradeAnalyst RevisionICUIICU Medical4.6755 of 5 stars$125.81-1.8%$179.00+42.3%-22.8%$3.16B$2.38B-82.7715,000Positive NewsInsider TradeXRAYDENTSPLY SIRONA4.9941 of 5 stars$14.40-1.8%$18.64+29.4%-43.6%$2.92B$3.79B-3.0414,000News CoveragePositive NewsHAEHaemonetics4.9547 of 5 stars$55.30-1.9%$85.18+54.0%-28.2%$2.72B$1.36B16.913,023Trending NewsAnalyst Revision Related Companies and Tools Related Companies Cerus Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Cooper Companies Competitors Align Technology Competitors Merit Medical Systems Competitors ICU Medical Competitors DENTSPLY SIRONA Competitors Haemonetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSUR) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access